We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$1.08B
Cap. Flow
+$1.18B
Cap. Flow %
16.06%
Top 10 Hldgs %
55.65%
Holding
321
New
63
Increased
80
Reduced
61
Closed
90

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
ICLR icon
Icon
ICLR
+$97.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$87.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$82.5M
5
GSK icon
GSK
GSK
+$66.7M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$40.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$36.7M
3
SHAK icon
Shake Shack
SHAK
+$32.9M
4
INCY icon
Incyte
INCY
+$30.5M
5
CYTK icon
Cytokinetics
CYTK
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 39.34%
2 Consumer Discretionary 6.39%
3 Consumer Staples 5.37%
4 Technology 5.27%
5 Communication Services 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVH icon
126
PVH
PVH
$4.04B
$4.21M 0.06%
+39,784
New +$4.08M
RSI icon
127
Rush Street Interactive
RSI
$2.88B
$3.77M 0.05%
275,000
-75,000
-21% -$912K
ZURA icon
128
Zura Bio
ZURA
$566M
$3.75M 0.05%
1,500,000
– –
KYNB
129
Kyntra Bio
KYNB
$29.4M
$3.6M 0.05%
272,000
– –
GRPN icon
130
Groupon
GRPN
$951M
$3.34M 0.05%
+275,000
New +$2.88M
ALUR
131
DELISTED
Allurion Technologies
ALUR
$3.24M 0.04%
301,096
-11,144
-4% -$151K
DNUT icon
132
Krispy Kreme
DNUT
$576M
$3.23M 0.04%
+325,000
New +$3.52M
IPAR icon
133
Interparfums
IPAR
$3.94B
$3.2M 0.04%
+24,352
New +$3.13M
RDDT icon
134
Reddit
RDDT
$31.1B
$3.11M 0.04%
+19,000
New +$2.35M
CTM icon
135
Castellum
CTM
$58.2M
$3.07M 0.04%
+1,535,505
New +$490K
BLMN icon
136
Bloomin' Brands
BLMN
$937M
$3.05M 0.04%
250,000
-50,000
-17% -$717K
CRBP icon
137
Corbus Pharmaceuticals
CRBP
$188M
$2.78M 0.04%
+236,000
New +$3.96M
ANRO icon
138
Alto Neuroscience
ANRO
$1.11B
$2.75M 0.04%
+650,000
New +$4.06M
RL icon
139
Ralph Lauren
RL
$23.5B
$2.69M 0.04%
+11,656
New +$2.48M
TOON icon
140
Kartoon Studios
TOON
$34.9M
$2.69M 0.04%
+4,562,000
New +$3.25M
ASMB icon
141
Assembly Biosciences
ASMB
$529M
$2.65M 0.04%
168,074
-185,926
-53% -$2.99M
ENLV icon
142
Enlivex Ltd
ENLV
$35M
$2.58M 0.04%
147,200
+4,600
+3% +$89.5K
FEAM icon
143
5E Advanced Materials
FEAM
$62.3M
$2.56M 0.04%
174,208
-42,314
-20% -$507K
AXDX
144
DELISTED
Accelerate Diagnostics
AXDX
$2.49M 0.03%
2,078,000
-23,000
-1% -$38.2K
RVPH
145
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$2.47M 0.03%
68,200
-91,100
-57% -$2.54M
LIVN icon
146
LivaNova
LIVN
$4.2B
$2.45M 0.03%
53,000
-117,477
-69% -$6.02M
ARAY icon
147
Accuray
ARAY
$34M
$2.45M 0.03%
1,236,000
+736,000
+147% +$1.39M
PMN icon
148
ProMIS Neurosciences
PMN
$132M
$2.38M 0.03%
100,399
-6,401
-6% -$159K
PTN
149
Palatin Technologies
PTN
$13.8M
$2.21M 0.03%
+39,857
New +$2.02M
GOOS
150
Canada Goose Holdings
GOOS
$856M
$2.16M 0.03%
215,000
-212,000
-50% -$2.17M
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Armistice Capital held 321 positions worth $7.33B, up 17% from $6.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital deployed $1.18B of net new capital in Q4 2024, opening 63 new positions and adding to 80 existing holdings. Its largest new stake was Exact Sciences: 1,617,000 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $36.7M trimmed.

  • Armistice Capital's largest Q4 2024 buy was Exact Sciences: 1,617,000 shares worth $90.9M.
  • Armistice Capital added most to Neurocrine Biosciences in Q4 2024, an estimated $87.9M increase.
  • Armistice Capital's biggest Q4 2024 reduction was PTC Therapeutics, cutting an estimated $36.7M.
  • Armistice Capital fully exited Alkermes in Q4 2024, selling an estimated $40.5M.
  • Armistice Capital's ten largest holdings make up 56% of its $7.33B portfolio in Q4 2024.
  • Armistice Capital opened 63 new positions and closed 90 in Q4 2024.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.